Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells

Carcinogenesis

Volumn 29, Issue 5, 2008, Pages 1049-1056

  Khan, Naghma ^a   Afaq, Farrukh ^a   Syed, Deeba N ^a   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYTOCHROME C; FISETIN; FLAVONOID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE; THREONINE; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRAIN LNCAP; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN INDUCTION;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CASPASE 7; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CYTOCHROMES C; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; FLOW CYTOMETRY; HUMANS; MALE; NEOPLASM PROTEINS;

EID: 47249134657     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn078     Document Type: Article

References (32)

1. Jemal,A. et al. (2007) Cancer statistics. CA Cancer J. Clin. 57, 43-66.
2. Syed,D.N. et al. (2007) Chemoprevention of prostate cancer through dietary agents: Progress and promise. Cancer Epidemiol. Biomarkers Prev., 16, 2193-2203.
3. Adhami,V.M. et al. (2006) Polyphenols from green tea and pomegranate for prevention of prostate cancer. Free Radic. Res., 40, 1095-1104.
4. Arai,Y. et al. (2000) Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr. 130, 2243-2250.
5. Lu,X. et al. (2005) Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells. J. Nutr., 135, 2884-2890.
6. Haddad,A.Q. et al. (2006) Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis., 9, 68-76.
7. Chen,Y.C. et al. (2002) Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol. 76, 351-359.
8. Lee,W.R. et al. (2002) Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochem. Pharmacol., 63, 225-236.
9. Maher,P. et al. (2006) Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc. Natl Acad Sci. USA 103, 16568-16573.
10. Sung,B. et al. (2007) Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-{kappa} B-regulated cell proliferation, anti-apoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated I{kappa}B{alpha} kinase activation. Mol. Pharmacol., 71, 1703-1714.
11. Ichimatsu,D. et al. (2007) Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 CI 41 cells. Mol. Carcinog., 46, 436-445.
12. Hou,D.X. et al. (2001) Fisetin induces transcription of NADPH:qUinone oxidoreductase gene through an antioxidant responsive element-involved activation. Int. J. Oncol., 18, 1175-1179.
13. de Sousa,R.R. et al. (2007) Phosphoprotein levels, MAPK activities and NFkappaB expression are affected by fisetin. J. Enzyme Inhib. Med. Chem., 22, 439-444.
14. Khan,N. et al. (2007) Apoptosis by dietary factors: The suicide solution for delaying cancer growth. Carcinogenesis, 28, 233-239.
15. Huang,Y. et al. (2001) Structural basis of caspase inhibition by XIAP: Differential roles of the linker versus the BIR domain. Cell 104, 781-790.
16. Michels,K.B. (2005) The role of nutrition in cancer development and prevention. Int. J. Cancer, 114, 163-165.
17. Khan,N. et al. (2008) Cancer chemoprevention through dietary antioxidants: Progress and promise. Antioxid Redox. Signal., 10 475-510.
18. Malik,A. et al. (2005) Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc. Natl Acad. Sci USA, 102, 14813-14818.
19. Kweon,M.H. et al. (2007) A novel. antioxidant 3-O-caffeoyl-1-methylquinic acid enhances ultraviolet A-mediated apoptosis in immortalized HaCaT keratinocytes via Sp1-dependent transcriptional activation of p21(WAF1/Cip1). Oncogene, 26, 3559-3571.
20. Sarfaraz,S. et al. (2006) Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest. J. Biol. Chem. 281, 39480-39491.
21. Sato,M. et al. (2007) A natural peptide, dolastatin 15, induces G2/M cell cycle arrest and apoptosis of human multiple myeloma cells. Int. J. Oncol., 30, 1453-1459.
22. Tian,Z. et al. (2008) Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells. Int. J. Cancer, 122, 31-38.
23. Ahmad,N. et al. (1998) Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis. Proc. Natl Acad. Sci. USA, 95, 6977-6982.
24. Sanchez,I. et al. (2005) New insights into cyclins, CDKs and cell cycle control. Semin. Cell Dev. Biol., 16, 311-321.
25. Oltersdorf,T. et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature, 435, 677-681.
26. Martinou,J.C. et al. (2000) Cytochrome c release from mitochondria: All or nothing. Nat. Cell Biol., 2, E41-E43.
27. Tsujimoto,Y. et al. (2000) Bcl-2 family: Life-or-death switch. FEBS Lett., 466, 6-10.
28. Igney,F.H. et al. (2002) Death and anti-death: Tumour resistance to apoptosis. Nat. Rev. Cancer, 2, 277-288.
29. Hofmann,H.S. et al. (2002) Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J. Cancer Res. Clin. Oncol., 128, 554-560.
30. Suzuki,Y. et al. (2001) Ubiquitin-protein ligase activity of X-linked inhibitor of aboptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl Acad. Sci. USA, 98, 8662-8667.
31. Takasawa,R. et al. (2003) Sustained release of Smac/DIABLO from mitochondria commits to undergo UVB-induced apoptosis: Apoptosis, 8, 291-299.
32. Hanahan,D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.